R.H. Bluestein & Co’s Colgate-Palmolive CL Stock Holding History

R.H. Bluestein & Co’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$211K	Hold	3,000	–	–	0.01%	317
2022 Q2	$240K	Hold	3,000	–	–	0.01%	306
2022 Q1	$227K	Hold	3,000	–	–	0.01%	355
2021 Q4	$256K	Hold	3,000	–	–	0.01%	355
2021 Q3	$227K	Sell	3,000 -2,000	-40%	-$159K	0.01%	377
2021 Q2	$407K	Hold	5,000	–	–	0.02%	262
2021 Q1	$394K	Sell	5,000 -8	-0.2%	-$627	0.02%	252
2020 Q4	$428K	Buy	5,008 +8	+0.2%	+$662	0.02%	212
2020 Q3	$386K	Hold	5,000	–	–	0.02%	201
2020 Q2	$366K	Hold	5,000	–	–	0.02%	195
2020 Q1	$332K	Hold	5,000	–	–	0.03%	160
2019 Q4	$344K	Buy	+5,000	New	+$341K	0.02%	245

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

R.H. Bluestein & Co's CL Position: Q3 2022 in Review

R.H. Bluestein & Co held its Colgate-Palmolive (CL) position steady in Q3 2022 at 3,000 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #317.

R.H. Bluestein & Co first reported a position in CL in Q4 2019 and has held it in 12 quarters since. The position peaked at $428K in Q4 2020. 1,615 funds tracked by Wall St. Rank hold CL as of Q3 2022.

R.H. Bluestein & Co held 3,000 shares of Colgate-Palmolive worth $211K as of Q3 2022.
R.H. Bluestein & Co left its Colgate-Palmolive share count unchanged in Q3 2022.
Colgate-Palmolive made up 0.01% of R.H. Bluestein & Co's portfolio in Q3 2022, its #317 holding.
R.H. Bluestein & Co first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 12 quarters since.
R.H. Bluestein & Co's Colgate-Palmolive position peaked at $428K in Q4 2020.
1,615 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.